Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet-induced mouse model of nonalcoholic fatty liver disease
Autors de IIS La Fe
Autors aliens a IIS La Fe
- Pisonero-Vaquero S
- Martínez-Ferreras Á
- García-Mediavilla MV
- Martínez-Flórez S
- Fernández A
- Olcoz JL
- González-Gallego J
- Sánchez-Campos S
Grups d'Investigació
Abstract
Scope: Flavonoids and related compounds seem to have favorable effects on nonalcoholic fatty liver disease (NAFLD) progression, although the exact mechanisms implicated are poorly understood. In this study, we aimed to investigate the effect of the flanovol quercetin on gene expression deregulation involved in the development of NAFLD, as well as the possible implication of phosphatidylinositol 3-kinase (PI3K)/AKT pathway modulation. Methods and results: We used an in vivo model based on methionine-and choline-deficient (MCD) diet-fed mice and an in vitro model consisting of Huh7 cells incubated with MCD medium. MCD-fed mice showed classical pathophysiological characteristics of nonalcoholic steatohepatitis, associated with altered transcriptional regulation of fatty acid uptake-and trafficking-related gene expression, with increased lipoperoxidation. PI3K/AKT pathway was activated by MCD and triggered gene deregulation causing either activation or inhibition of all studied genes as demonstrated through cell incubation with the PI3K-inhibitor LY294002. Treatment with quercetin reduced AKT phosphorylation, and oxidative/nitrosative stress, inflammation and lipid metabolism-related genes displayed a tendency to normalize in both in vivo and in vitro models. Conclusion: These results place quercetin as a potential therapeutic strategy for preventing NAFLD progression by attenuating gene expression deregulation, at least in part through PI3K/AKT pathway inactivation.
Dades de la publicació
- ISSN/ISSNe:
- 1613-4125, 1613-4133
- Tipus:
- Article
- Pàgines:
- 879-893
- PubMed:
- 25712622
- Factor d'Impacte:
- 1,702 SCImago ℠
- Quartil:
- Q1 SCImago ℠
MOLECULAR NUTRITION & FOOD RESEARCH WILEY
Cites Rebudes en Web of Science: 89
Documents
- No hi ha documents
Filiacions
Keywords
- Fatty acid uptake; Lipid metabolism; NAFLD; PI3K/AKT pathway; Quercetin
Projectes associats
DESARROLLO DE UN MODELO HEPATOCELULAR HUMANO DIFERENCIADO PARA ESTUDIOS DE METABOLISMO Y POTENCIAL INDUCTOR DE NUEVOS FARMACOS
Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL
SAF2003-09353 . 2003
DEVELOPMENT OF A HIGH THROUGHPUT GENOMICS-BASED TEST FOR ASSESSING GENOTOXIC AND CARCINOGENIC PROPERTIES OF CHEMICAL COMPOUNDS IN VITRO
Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL
CARCINOGENOMICS . COMISION EUROPEA . 2006
LINTOP
Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL
LSHB-CT-2006-037499 - LINTOP . FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2005
MECANISMOS TRNACRIPCIONALES IMPLICADOS EN LA ETIOLOGIA DEL HIGADO GRASO NO ALCOHOLICO. ESTUDIOS EN UN MODELO CELULAR HUMANO DE ESTEATOSIS Y APLICACION AL TRANSPLANTE DE HEPATOCITOS EN TERAPIA CELULAR.
Investigador Principal: RAMIRO JOVER ATIENZA
PI07/0550 . INSTITUTO DE SALUD CARLOS III . 2007
MECANISMOS TRANSCRIPCIONALES IMPLICADOS EN EL HIGADO GRASO NO ALCOHOLICO DE ORIGEN METABOLICO E IATROGENICO: INFLUENCIA DE LA RESISTENCIA A LA INSULINA
Investigador Principal: RAMIRO JOVER ATIENZA
PI10/00194 . INSTITUTO DE SALUD CARLOS III . 2010
ESTEATOSIS HEPÁTICA POR MEDICAMENTOS: NUEVOS MECANISMOS Y BIOMARCADORES APLICABLES AL DESARROLLO FARMACÉUTICO Y A UNA TERAPIA MÁS RACIONAL EN PACIENTES CON SÍNDROME METABÓLICO.
Investigador Principal: RAMIRO JOVER ATIENZA
PI13/01470 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2014